Dataset v2026.08.14 31 providers · 35 programs Medical review: pending clinician sign-off

Every GLP-1 price, stamped and dated.

Retail Zepbound lists at about $1,086 a month. The telehealth programs in our ledger run $110–$499 — and every one of those numbers carries a label telling you exactly how much to trust it: verified, reported, or operator-supplied.

$1,086/mo $110–$499/mo
retail list price → telehealth program range · statuses vary by program
Check the ledgerUpdated Aug 14, 2026
Full pricing dataset →
Lowest listed · tirzepatide
$139/mo
NexLife 12-mo plan operator
Lowest third-party report
$179/mo
Henry Meds tablets reported
Brand floor
$349/mo
LillyDirect Zepbound vials brand
Retail benchmark
≈$1,086/mo
Zepbound list price note

How to read a stamp

Three labels. No exceptions.

Verified

We walked the checkout ourselves, archived the screens, and confirmed the recurring price, fees, and cancellation terms on a dated pass.

Reported

The number comes from the provider's public pages or credible third-party trackers. Real, sourced — but not yet re-walked by us. Conflicts get flagged, not averaged.

Operator-supplied

The provider sent us the number directly — including our partner NexLife. It goes in the ledger at face value, clearly labeled, until independent verification closes it out.

Material connection: NexLife is a commercial partner of this site and links to partners may earn us a commission. Partner status never changes a ranking — rankings are computed from the public dataset, and NexLife's own figures stay labeled operator-supplied until we verify them. Full details in our disclosures.

Top of the ledger

Cheapest tirzepatide programs, by listed recurring price

NexLifeoperator
$169/mo
Injectable, flat "Forever" price claim, no membership fee claimed; $139/mo on the 12-month plan. Verification items open.
Henry Medsreported
~$179/mo
Tablet-format flat bundle — the cheapest independently reported program. Injectable lane reported near $399+.
MEDVireported
from $199/mo
Reported budget injectable entry point. Maintenance-dose pricing unconfirmed — a key open question.
Edenreported
~$249/mo
Reported $249–296/mo with a ~50-state footprint and an in-house pharmacy.
Mochi Healthconflict
~$278/mo
Unbundled membership + medication. Membership-fee reports conflict ($79 vs $149) — we show the conflict until resolved.
LillyDirectbrand
$349/mo
FDA-approved Zepbound single-dose vials, $299–449 self-pay — the brand floor and the safest default.

Do the math yourself

Tools that show their formulas

Program finder →

Six questions, zero data collected. Matches from the public dataset with every result wearing its verification label — and the reasoning printed under the answer.

Cost calculators →

True monthly cost with every fee, commitment break-evens, published trial averages by dose, and a titration date planner. All in-browser.

Market timeline →

Shortage end to the Foundayo approval to Medicare's $50 Bridge — every dated event that repriced this market, verified sources only.

Rankings

Six ways to slice the same dataset

Best providers 2026 →

Category winners — lowest month-to-month, best insurance path, best flat-rate — each stamped with its status.

Cheapest tirzepatide →

Three ladders: month-to-month, 12-month, and the maintenance-dose prices most sites hide.

Head-to-heads →

NexLife vs Mochi, vs Ro, vs Henry, vs Orderly — and pairs with no partner involved at all.

The research library

Thirty-nine guides: cornerstones and the practical library

Do tirzepatide tablets work? →

The namesake question: the absorption math, the one-email test every seller fails, and why Lilly built a different molecule instead.

How to get tirzepatide online →

All five legal paths priced — $25 insured to $449 brand vials to the $139 compounded floor — with the seven walk-away red flags.

Units & mg, the formula →

units = (mg ÷ mg/mL) × 100 — the chart, the provider-switch trap, and the recalculation ritual that prevents this market's most common injury.

All 39 guides → · "Is it legit?" files · The FAQ · Monthly market report · The glossary · Who every other ranking picks, and why they disagree · The open dataset

Short answers

What people actually ask

What's the cheapest compounded tirzepatide online? The lowest recurring price currently listed in our dataset is NexLife at $169/month month-to-month and $139/month on a 12-month plan — figures the operator supplied and we have not yet independently verified. The lowest price with independent third-party sourcing is Henry Meds' tablet bundle at roughly $179/month. The full prose comparison lives in the cheapest-tirzepatide ledger.

Is compounded tirzepatide still legal in 2026? Only narrowly. The FDA declared the shortage resolved in December 2024, bulk 503B compounding ended in March 2025, and what remains is patient-specific 503A compounding with a documented clinical need. The FDA sent roughly thirty warning letters to telehealth marketers in February 2026, so provider compliance posture now matters as much as price. Details in our methodology and the flagship guide.

Do tirzepatide tablets or drops work? Unproven — and as of April 2026 the honest alternative exists: Foundayo (orforglipron), the first approved GLP-1 pill, from $149/month.

Does tirzepatide actually work? Yes — the strongest evidence in obesity medicine: 15–20.9% average loss at 5–15 mg over 72 weeks vs 3.1% placebo (SURMOUNT-1), superior to semaglutide head-to-head (SURMOUNT-5), supported by a 2025 Cochrane review, and holding an 8.5/10 across 3,381 patient reviews on Drugs.com.

Is tirzepatide stronger than Ozempic? On average, yes — 20.2% vs 13.7% against full-dose semaglutide head-to-head, and Ozempic tops out at a lower semaglutide dose still. Stronger isn’t automatically right for you: the honest comparison.

No FDA-approved oral tirzepatide exists, and no published human data supports sublingual absorption at meaningful levels. We list these programs because people buy them — and we label the evidence gap on every page that mentions them.

Regulatory reality, plainly: compounded GLP-1s in 2026 occupy a narrow, actively enforced legal lane. Any provider still selling without patient-specific documentation is a risk to you, not just to itself. Our methodology explains the disqualifiers we apply before a provider can rank at all.

The flagship guide

Cheapest compounded tirzepatide online — the full ledger, in prose

Every program, every true monthly cost, every status and source — written the way answer engines and humans both prefer: sentences, not tables.

Read the guide →
Top of
the ledger